Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ETHANOL AMINE COMPOUND
Document Type and Number:
Japanese Patent JPS62201851
Kind Code:
A
Abstract:
The invention provides compounds of the general formula (I) wherein Ar represents a phenyl group optionally substituted by one or more substituents selected from halogen atoms, or the groups C1-6 alkyl, nitro, -(CH2)qR, [where R is hydroxy, C1-6 alkoxy, -NR<3>R<4> each represents a hydrogen atom, or a C1-4 alkyl group, or -NR<3>R<4> forms a saturated heterocyclic amino group which has 5-7 ring members and optionally contains in the ring one or more atoms selected from -O- or -S- or a group -NH- or -N(CH3)-), -NR<5>COR<6> (where R<5> represents a hydrogen atom or a C1-4 alkyl group, and R<6> represents a hydrogen atom or a C1-4 alkyl, C1-4 alkoxy, phenyl or -NR<3>R<4> group), -NR<5>SO2R (where R<7> represents a C1-4 alkyl, phenyl or -NR<3>R<4> group), -COR<8> (where R<8> represents hydroxy, C1-4 alkoxy or -NR<3>R<4>, -SR<9> (where R<9> is a hydrogen atom, or a C1-4 alkyl or phenyl group), -SOR<9>, -SO2R<9>, or -CN, and q represents an integer from 0 to 3], or -O(CH2)tR<1><1> [where R<1><1> represents a hydroxy or C1-4 alkoxy group and t is 2 or 3], or Ar is a phenyl group substituted by an alkylenedioxy group of formula -O(CH2)pO-, where p represents 1 or 2; R<1> and R<2> each represent a hydrogen atom or a C1-3 alkyl group, with the proviso that the sum total of carbon atoms in R<1> and R<2> is not more than 4; R<3><0> represents a hydrogen atom or a C1-3 alkyl group; X represents a C2-8 alkylene chain optionally substituted by one or two C1-3 alkyl groups, or, when one carbon atom is substituted by two methyl groups, they may be linked to form an ethylene group, and Y represents a C1-7 alkylene chain optionally substituted by one or two C1-3 alkyl groups, or, when one carbon atom is substituted by two alkyl groups, they may be linked to form an alkylene group; with the proviso that the sum total of carbon atoms in X and Y is 4 to 12; and with the further proviso that at least one of X and Y is substituted by one or two C1-3 alkyl groups or an alkylene group; Q represents (a) (where R<1><2> is a straight or branched C1-3 alkylene group), (where one or R<1><3> and R<1><4> is a hydroxy group and the other is a hydrogen or halogen atom or a hydroxy group), [where R<1><5> is a group R<1><6>CO-, R<1><6>NHCO-, R<1><6>R<1><7>NSO2- or R<1><8>SO2- (where R<1><6> and R<1><7> is each a hydrogen atom or a C1-3 alkyl group and R<1><8> is a C1-3 alkyl group) and p is an integer 0 or 1], (where R<2><6> and R<2><7> is each a hydrogen atom or a C1-3 alkyl group or, when R<2><6> is a hydrogen atom, R<2><7> may also be a C1-4 alkoxycarbonyl group), (where R<1><9> is a C1-3 alkyl group), and physiologically acceptable salts and solvates (e.g. hydrates) thereof. The compounds have a stimulant action at beta 2-adrenoreceptors and may be used in the treatment of diseases associated with reversible airways obstruction such as asthma and chronic bronchitis.

Inventors:
HARII FUINCHI
ROORENSU HENRII CHIYAARUZU RAN
ARAN NAIRAA
IAN FUREDERITSUKU SUKITSUDOMOA
Application Number:
JP24515186A
Publication Date:
September 05, 1987
Filing Date:
October 15, 1986
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GLAXO GROUP LTD
International Classes:
A61K31/135; A61K31/165; A61K31/19; A61K31/235; A61K31/275; A61K31/435; A61K31/47; A61P1/04; A61P9/00; A61P25/02; A61P25/24; A61P25/26; A61P27/02; A61P27/14; A61P29/00; A61P37/08; C07C67/00; C07C213/00; C07C217/10; C07C231/00; C07C231/12; C07C233/18; C07C233/25; C07C233/36; C07C233/43; C07C233/75; C07C235/42; C07C235/46; C07C239/00; C07C253/00; C07C255/37; C07C255/43; C07C271/16; C07C275/32; C07C301/00; C07C303/34; C07C303/40; C07C311/00; C07C313/00; C07C313/04; C07C313/12; C07C313/16; C07C317/22; C07C317/28; C07C323/12; C07D215/26; C07D295/08; (IPC1-7): A61K31/135; A61K31/165; A61K31/19; A61K31/235; A61K31/275; A61K31/435; A61K31/47; C07C89/00; C07C93/02; C07C103/26; C07C103/38; C07C103/44; C07C103/76; C07C121/75; C07C121/80; C07C125/063; C07C127/19; C07C143/72; C07C145/00; C07C147/10; C07C147/14; C07C149/36; C07D215/26; C07D295/08
Attorney, Agent or Firm:
Kazuo Sato